- Home
- SGRY vs ASH Comparison
SGRY vs ASH Comparison
Compare SGRY & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRY
- ASH
- Stock Information
- Founded
- SGRY 2004
- ASH 1924
- Country
- SGRY United States
- ASH United States
- Employees
- SGRY N/A
- ASH N/A
- Industry
- SGRY Hospital/Nursing Management
- ASH Specialty Chemicals
- Sector
- SGRY Health Care
- ASH Consumer Discretionary
- Exchange
- SGRY Nasdaq
- ASH Nasdaq
- Market Cap
- SGRY 2.7B
- ASH 2.8B
- IPO Year
- SGRY 2015
- ASH N/A
- Fundamental
- Price
- SGRY $23.95
- ASH $58.78
- Analyst Decision
- SGRY Buy
- ASH Buy
- Analyst Count
- SGRY 8
- ASH 6
- Target Price
- SGRY $37.57
- ASH $85.40
- AVG Volume (30 Days)
- SGRY 989.6K
- ASH 894.2K
- Earning Date
- SGRY 03-03-2025
- ASH 04-29-2025
- Dividend Yield
- SGRY N/A
- ASH 2.75%
- EPS Growth
- SGRY N/A
- ASH N/A
- EPS
- SGRY N/A
- ASH N/A
- Revenue
- SGRY $3,114,300,000.00
- ASH $2,045,000,000.00
- Revenue This Year
- SGRY $10.62
- ASH N/A
- Revenue Next Year
- SGRY $9.29
- ASH $3.06
- P/E Ratio
- SGRY N/A
- ASH N/A
- Revenue Growth
- SGRY 13.52
- ASH N/A
- 52 Week Low
- SGRY $19.50
- ASH $54.86
- 52 Week High
- SGRY $33.97
- ASH $102.50
- Technical
- Relative Strength Index (RSI)
- SGRY 45.89
- ASH 48.19
- Support Level
- SGRY $23.85
- ASH $56.56
- Resistance Level
- SGRY $24.59
- ASH $60.83
- Average True Range (ATR)
- SGRY 0.45
- ASH 1.54
- MACD
- SGRY -0.01
- ASH 0.66
- Stochastic Oscillator
- SGRY 52.03
- ASH 69.68
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.
About ASH Ashland Inc.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.